Jonathan Soll

Investment Stage

Focus Areas

About Investor

Jonathan Soll is a Senior Associate at New Rhein Healthcare Investors, based in Philadelphia, specializing in life sciences investments with a focus on Medical Devices, Pharmaceuticals, Consumer Health, BioTech, Diagnostics, Drug Delivery, Therapeutics, and Digital Health, typically at Seed and Series A stages with investment ranges between $20.0M and $50.0M. He joined New Rhein in May 2022, focused on sourcing and evaluating new investment opportunities as well as supporting portfolio companies. Prior to New Rhein, he was an Analyst at Denovo Capital Group, an event-driven investment fund, where he developed a successful investment strategy targeting special situations within the healthcare sector. He began his career in data analytics at Quicken Loans. He holds a BBA from the Stephen M. Ross School of Business at the University of Michigan.